Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis CHF 435M Bond (1.650%, 2024–2031) by Year
CHF 435M Bond (1.650%, 2024–2031) ($M)
Novartis CHF 435M Bond (1.650%, 2024–2031): $548M in FY2025, up 13.9% from a year earlier.
Latest, FY2025
548
Period ended Dec 31, 2025
Change on a year earlier
+13.9%
481 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Form 20-F (0001114448-26-000004)
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 19.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CHF 435M Bond (1.650%, 2024–2031) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 548 | +13.9% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 481 | – | Novartis Form 20-F (0001114448-26-000004) ↗ |
Cite this data
StockData. (2026). Novartis CHF 435M Bond (1.650%, 2024–2031) ($M), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bond-4-a1-650chf435million20242031novartisagbasel
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.